Timely and relevant thoracic oncology news brought to you by the only true global association dedicated to the multi-disciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only true global association dedicated to the multi-disciplinary study of lung cancer.

low-dose computed tomography

Add ILCN as a preferred source

June 23, 2020

On the Backs of Specialists: LDCT Screening Has Heightened the Importance of Recent Improvements in Surgical and Radiation Techniques

Lung Cancer Screening

By Brendon Stiles, MD, and Drew Moghanaki, MD, MPH Posted: June 24, 2020 Annual low-dose computed tomography (LDCT) detects more early-stage lung cancers and saves lives by preventing death in people who develop lung cancer. The recent report on the long-term follow-up of patients in the National Lung Screening Trial (NLST) makes a powerful argument…
April 16, 2020

Disparities in Meeting Eligibility Criteria for Lung Cancer Screening

Lung Cancer Risk Reduction & Prevention

By Kim L. Sandler, MD, Melinda C. Aldrich, MPH, PhD, and Jeffrey D. Blume, PhD Posted: April 16, 2020 IN REFERENCE TO: Aldrich MC, Mercaldo SF, Sandler KL, Blot WJ, Grogan EL, Blume JD. Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers. JAMA Oncol. 2019 Jun 27. [Epub ahead of print].…
April 15, 2020

A Cloud-Based Computerized System for the Korean Lung Cancer Screening Project

Lung Cancer Risk Reduction & Prevention

By Jin Mo Goo, MD, PhD, and Yeol Kim, MD, MPH, PhD Posted: April 16, 2020 Dr. Jin Mo Goo Dr. Yeol Kim In 2015, based on the evidence from the National Lung Screening Trial, the Korean multisociety collaborative committee developed and published a…

low-dose computed tomography

On the Backs of Specialists: LDCT Screening Has Heightened the Importance of Recent Improvements in Surgical and Radiation Techniques

Disparities in Meeting Eligibility Criteria for Lung Cancer Screening

COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection

Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy

Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC

No “Known” Risk Factors: The Health Consequences of Radiation Therapy

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging

No PFS, OS Benefit Seen in Final Results from PACIFIC-2

WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers

Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture

A Holistic Approach to Patient Care